Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T17:33:02.231Z.
Calculation as of: 2026-10-06T17:33:02.231Z.
Quote observation: 2026-10-06T17:30:03.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 65e01e2061821370315a71c231e2ba412a336584d38d2dbcbde0d0d1c3e2cd16
PEG RATIO
N/A
Mobia Medical, Inc. Common Stock
Market Cap
$303.13M
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| Mobia Medical, Inc. Common Stock (MOBI) | $303.13M | N/A |
| Benitec Biopharma Inc. (BNTC)vs › | $302.21M | N/A |
| C4 Therapeutics, Inc. (CCCC)vs › | $312.90M | N/A |
| Larimar Therapeutics, Inc. (LRMR)vs › | $290.35M | N/A |
| Standard BioTools Inc. (LAB)vs › | $289.84M | N/A |
| Cabaletta Bio, Inc. (CABA)vs › | $319.59M | N/A |
| ClearPoint Neuro, Inc. (CLPT)vs › | $319.69M | N/A |
| Avita Medical Inc. (RCEL)vs › | $319.61M | N/A |
| Sagimet Biosciences Inc. (SGMT)vs › | $285.74M | N/A |
| Sanara MedTech Inc. (SMTI)vs › | $321.44M | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
